In 2022, the AlphaFold artificial intelligence developed by Google Deepmind managed to find more than 200 million protein structures that can be used...
Vous n'êtes pas connecté
A computational model built by researchers at the Institute of Research in Biomedicine (IRB Barcelona) and the Centre for Genomic Regulation (CRG), Spain, can predict which drugs will be most effective in treating diseases caused by mutations that can bring protein synthesis to a halt, resulting in unfinished proteins. The findings, published today in Nature Genetics, [...]
In 2022, the AlphaFold artificial intelligence developed by Google Deepmind managed to find more than 200 million protein structures that can be used...
In 2022, the AlphaFold artificial intelligence developed by Google Deepmind managed to find more than 200 million protein structures that can be used...
TIANJIN, July 7 (Xinhua) -- A Chinese research team has developed a novel system to enable non-invasive and dynamic monitoring of blood sodium levels,...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and beta-thalassemia, and...
Western Australian researchers have developed an AI algorithm to better predict the risk of heart disease in a more personalised way.
Western Australian researchers have developed an AI algorithm to better predict the risk of heart disease in a more personalised way.
ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the...
Citrate is essential for the metabolism and development of neurons. A membrane transport protein called SLC13A5 plays a central role in this process...
The global biologics market is estimated to be valued at USD 450.2 billion in 2025 and is projected to reach USD 1,077.2 billion by 2035, registering...
The global biologics market is estimated to be valued at USD 450.2 billion in 2025 and is projected to reach USD 1,077.2 billion by 2035, registering...